Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

"Just Another Statistic"

Machtay1, Glatstein

  • 1Department of Radiation Oncology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, 19104, USA.

The Oncologist
|July 1, 1999
PubMed
Summary

Disease-specific survival (DSS) can overestimate cancer treatment effectiveness due to potential bias in cause-of-death interpretation. Researchers must report overall survival (OS) alongside DSS and describe intercurrent deaths to ensure accurate reporting.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Classification of Non-Hodgkin's Lymphoma: A Proposal.

The oncologist·1997
Same author

We've Got a Treatment, but What's the Disease? Or A Brief History of Hypofractionation and Its Relationship to Stereotactic Radiosurgery.

The oncologist·1996
Same author

To Lap or Not to Lap.

The oncologist·1996
Same author

Beware the Medical-Industrial Complex.

The oncologist·1996

Area of Science:

  • Oncology
  • Biostatistics
  • Clinical Trials

Background:

  • Disease-specific survival (DSS) is frequently used in cancer research to assess treatment efficacy.
  • However, DSS calculations can be influenced by how deaths are categorized, particularly deaths from intercurrent diseases.

Purpose of the Study:

  • To critically evaluate the limitations and potential biases associated with using disease-specific survival (DSS) as a primary endpoint in cancer clinical trials.
  • To highlight the importance of considering overall survival (OS) and the accurate classification of causes of death.

Main Methods:

  • Review of existing literature and statistical methodologies for survival analysis in oncology.
  • Discussion of potential biases, including cause-of-death interpretation and intercurrent mortality.
  • Analysis of hypothetical and real-world clinical scenarios to illustrate biases.

Main Results:

  • Disease-specific survival (DSS) rates are consistently higher than overall survival (OS) rates.
  • The classification of deaths as cancer-related versus intercurrent can be subjective and lead to significant interobserver variability.
  • Over-reliance on DSS may inflate the perceived effectiveness of cancer treatments, especially in older or sicker patient populations.

Conclusions:

  • Disease-specific survival (DSS) should be reported alongside overall survival (OS) in cancer research.
  • Clear guidelines and independent review are needed for cause-of-death determination to minimize bias.
  • Skepticism and critical appraisal of survival data, considering patient demographics and potential biases, are essential for readers of medical literature.

Related Experiment Videos